The chemical industry associations of the US, Canada, and Mexico met in Washington to launch joint initiatives tackling trade barriers and supply chain rules as the USMCA heads toward its 2026 review.
Simulation Unlocks Capacity, Boosts Reliability, Drives Smarter Decisions
GSK has agreed to acquire US clinical-stage oncology specialist Nuvalent for $10.6 billion, its largest deal in years, to accelerate entry into lung cancer and boost growth through the dolutegravir patent cliff.
Axplora is repositioning its Italian Farmabios site on high-potency APIs as UDCA production moves to its FDA-approved Vizag facility in India, consolidating supply and scaling for global demand.
Siemens and HighByte have joined forces to solve industrial data fragmentation. HighByte's Intelligence Hub connects OT and IT data sources to help manufacturers build and scale industrial AI applications.
IMCD has extensively modernized the application laboratories for Coatings & Construction and Home Care I&I and has now reopened them at BioCampus Cologne, a technology and innovation campus in Cologne.
Röhm's LiMA technology is in full industrial operation in Bay City, Texas (USA).
A clear signal to Berlin: the pharmaceutical companies Eli Lilly and Boehringer Ingelheim are canceling planned investments in Germany.
Sasol is expanding its Brunsbüttel site with a €60 million investment to boost specialty alumina production and strengthen supply for critical catalyst applications. Operations targeted for 2029.
Evonik has opened its first center for beauty science and innovation in Asia at the Evonik Shanghai Innovation Park in China.
Sygnature Discovery has partnered with AI firm DaltonTx to sharpen its drug discovery pipeline, bringing faster medicinal chemistry decisions and tighter data privacy to its CRO offering.
Northway Biotech is finalizing the Baltic region's most advanced cell therapy center — a 3,500 m² facility at Vilnius City Innovation Industrial Park, set to open Q3 2025.
The digital and intelligent development of the petroleum and chemical industry is a major component of China's 15th five-year plan for chemicals.
Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate (ADC) technology from The Noguchi Institute.
Dow has signed a long-term deal with Univar Solutions to distribute its Decarbia low-carbon product line — spanning beauty, food, pharma, and industrial markets — through Univar's global network.
The chemical and pharmaceutical industry got off to a weak start in 2026. Seasonally adjusted production fell by 2.8% in the first quarter. This was almost 6% lower than in the previous year.
Covestro has opened its new thermoplastic polyurethanes (TPU) Application Development (AD) Center in Guangzhou, China.
Budenheim Life Sciences is expanding its preventive and specialized nutrition portfolio in the Americas with the launch of a chelated minerals portfolio.
Wacker has sold 2.1 million Siltronic shares for € 89.35 per Siltronic share. The sale corresponds to 7% of Siltronic's share capital and reduces Wacker's stake in Siltronic to around 24%.
Acquisition strengthens US peptide manufacturing capabilities and broadens global expertise in complex peptide APIs
Chemistry start-up competition From Lab to Market Challenge partners with CHEManager to bridge the gap from scientific research to commercialization, offering founders media exposure, mentoring, and €10,000 in prizes.
African start-up Rôbalôtô, based in Togo, has developed an integrated system to manage plastic waste more efficiently and support circular economy by combining technology, recycling, and education.
Irish water treatment specialist CSG acquires UK distributor Resource Chemicals, pushing group revenue past €100 million and advancing its strategy to build a full-service platform across Ireland and the UK.
Catalent partners with non-profit Elpida Therapeutics to support late-phase AAV manufacturing for a rare neurological gene therapy, securing exclusive rights across Elpida's broader AAV pipeline.
Alcami completes its acquisition of Tjoapack, creating a 1,400-strong CDMO with over one million square feet of operations across the US and the Netherlands, adding European packaging scale and QP release services.
Hongene Biotech delivers end-to-end CDMO services for SiranBio's dual-target siRNA hepatitis B candidate, from raw materials through cGMP manufacturing, highlighting its capabilities in oligonucleotide therapeutics.
Bristol Myers Squibb licenses Lonza's SYNtecan linker-payload platform to advance an undisclosed ADC target, with Lonza eligible for upfront payments, milestones and royalties on resulting products.
Piramal Pharma Solutions opens a new payload-linker suite in Michigan as part of a $90 million US investment plan, bolstering its ADC manufacturing capabilities across sites in Riverview and Lexington.
Eli Lilly adds $4.5 billion to its Indiana manufacturing programme, funding a new genetic medicine facility and expanded API capacity at Lebanon, taking its total US investment since 2020 past $50 billion.
Abu Dhabi's Ta'ziz signs a $10 billion chemicals deal with Alpha Dhabi and closes $2bn in methanol plant financing, marking over $12 billion in new investment at Al Ruwais Industrial City.
Symeres, a transatlantic CRDMO for drug discovery and development, announced the appointment of Henning Steinhagen as Chief Executive Officer.
Takeda has officially commissioned a new photovoltaic system at its production site in Oranienburg near Berlin.
BASF Agricultural Solutions has successfully commissioned its BioHub, a new fermentation plant for biological and biotechnology-based crop protection products, at the Ludwigshafen site.
By investing in a new steam compressor at the Dormagen site, Covestro will reduce its energy requirements in Germany by 2% per year compared to 2025.
Bayer and BP start a long-term strategic cooperation to market the oilseed camelina under the Newgold brand for the production of biofuels.
